Kamat Drug Patent Portfolio

Kamat owns 1 orange book drug protected by 1 US patent Given below is the list of Kamat's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8133893 Trazodone and trazodone hydrochloride in purified form 13 Mar, 2029
Active


Given below is the list of recent legal activities going on the following drug patents of Kamat.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 06 Sep, 2023 US8133893
Payment of Maintenance Fee, 8th Year, Large Entity 05 Sep, 2019 US8133893
Post Issue Communication - Certificate of Correction 13 Aug, 2012 US8133893
Recordation of Patent Grant Mailed 13 Mar, 2012 US8133893
Patent Issue Date Used in PTA Calculation 13 Mar, 2012 US8133893
Email Notification 23 Feb, 2012 US8133893
Issue Notification Mailed 22 Feb, 2012 US8133893
Dispatch to FDC 09 Feb, 2012 US8133893
Printer Rush- No mailing 01 Feb, 2012 US8133893
Pubs Case Remand to TC 31 Jan, 2012 US8133893
Application Is Considered Ready for Issue 25 Jan, 2012 US8133893
Issue Fee Payment Received 24 Jan, 2012 US8133893
Issue Fee Payment Verified 24 Jan, 2012 US8133893
Electronic Review 10 Jan, 2012 US8133893
Email Notification 10 Jan, 2012 US8133893


Kamat's Family Patents

Kamat drugs have patent protection in a total of 23 countries. It's US patent count contributes only to 42.9% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Kamat Drug List

Given below is the complete list of Kamat's drugs and the patents protecting them.


1. Raldesy

Raldesy is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8133893 Trazodone and trazodone hydrochloride in purified form 13 Mar, 2029
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Raldesy's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List